We are live on
!
Find out more
GC
Gratus Capital Portfolio holdings
AUM
$2.5B
1-Year Est. Return
32.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.1%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
–
AUM
$680M
AUM Growth
+$224M
(+49%)
Cap. Flow
+$222M
Cap. Flow
% of AUM
32.67%
Top 10 Holdings %
Top 10 Hldgs %
44.16%
Holding
182
New
111
Increased
38
Reduced
20
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAL
Valspar
VAL
|
+$8.08M |
| 2 |
Danaher
DHR
|
+$7.52M |
| 3 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$6.44M |
| 4 |
Graco
GGG
|
+$6.38M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$6.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$6.37M |
| 2 |
Medtronic
MDT
|
+$2.22M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$2.08M |
| 4 |
DuPont de Nemours
DD
|
+$2.06M |
| 5 |
Invesco Large Cap Value ETF
PWV
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 34.55% |
| 2 | Financials | 10.83% |
| 3 | Healthcare | 10.25% |
| 4 | Industrials | 9.41% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
D.R. Horton
DHI
$41B
| $296K | 0.04% |
+9,400
| New | +$287K |
|
152
Cognizant
CTSH
$21.5B
| $286K | 0.04% |
5,000
| – | – |
|
|
TUP
153
DELISTED
Tupperware Brands Corporation
TUP
| $284K | 0.04% |
+5,039
| New | +$288K |
|
154
FMC
FMC
$1.42B
| $278K | 0.04% |
+6,918
| New | +$271K |
|
155
Honda
HMC
$36.5B
| $266K | 0.04% |
+10,500
| New | +$283K |
|
156
Merck
MRK
$324B
| $265K | 0.04% |
4,830
-2,572
| -35% | -$137K |
|
157
NorthWestern Energy
NWE
$4.48B
| $265K | 0.04% |
+4,200
| New | +$249K |
|
158
Invesco QQQ Trust
QQQ
$455B
| $265K | 0.04% |
+2,464
| New | +$266K |
|
159
Unilever
UL
$131B
| $265K | 0.04% |
4,919
| – | – |
|
160
AT&T
T
$165B
| $256K | 0.04% |
+7,858
| New | +$234K |
|
161
Martin Marietta Materials
MLM
$33.6B
| $250K | 0.04% |
+1,300
| New | +$233K |
|
162
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $245K | 0.04% |
5,726
+646
| +13% | +$28K |
|
163
AGCO
AGCO
$8.78B
| $240K | 0.04% |
+5,102
| New | +$262K |
|
164
Suncor Energy
SU
$77.7B
| $237K | 0.03% |
+8,550
| New | +$234K |
|
165
Biogen
BIIB
$29.9B
| $222K | 0.03% |
920
-130
| -12% | -$34.3K |
|
166
Western Union
WU
$2.57B
| $220K | 0.03% |
+11,450
| New | +$222K |
|
|
SRCL
167
DELISTED
Stericycle Inc
SRCL
| $208K | 0.03% |
2,000
| – | – |
|
|
MMP
168
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $203K | 0.03% |
+2,667
| New | +$189K |
|
|
JOF
169
Japan Smaller Capitalization Fund
JOF
$320M
| $173K | 0.03% |
+17,669
| New | +$171K |
|
170
Opko Health
OPK
$921M
| $157K | 0.02% |
+16,775
| New | +$170K |
|
171
ICICI Bank
IBN
$106B
| $144K | 0.02% |
+22,107
| New | +$142K |
|
|
MPX
172
DELISTED
Marine Products Corp
MPX
| $113K | 0.02% |
+13,299
| New | +$110K |
|
|
STRM
173
DELISTED
Streamline Health Solutions
STRM
| $103K | 0.02% |
5,721
| – | – |
|
|
CDI
174
DELISTED
CDI Corp.
CDI
| $103K | 0.02% |
+16,865
| New | +$108K |
|
175
Ambev
ABEV
$47.3B
| $74K | 0.01% |
12,500
| – | – |
|
Similar funds
LFDLE
CDH
AT
BPCA
HIG
H
PRIG
PO
Gratus Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Gratus Capital held 182 positions worth $680M, up 49% from $456M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Gratus Capital deployed $222M of net new capital in Q2 2016, opening 111 new positions and adding to 38 existing holdings. Its largest new stake was Valspar: 75,300 shares worth $8.13M.
By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, down from 47% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $2.22M trimmed.
- Gratus Capital's largest Q2 2016 buy was Valspar: 75,300 shares worth $8.13M.
- Gratus Capital added most to Berkshire Hathaway Class B in Q2 2016, an estimated $6.38M increase.
- Gratus Capital's biggest Q2 2016 reduction was Medtronic, cutting an estimated $2.22M.
- Gratus Capital fully exited AbbVie in Q2 2016, selling an estimated $6.37M.
- Gratus Capital's ten largest holdings make up 44% of its $680M portfolio in Q2 2016.
- Gratus Capital opened 111 new positions and closed 5 in Q2 2016.
- Gratus Capital's portfolio value rose 49% quarter-over-quarter to $680M.
Based on Gratus Capital's 13F filing for Q2 2016, filed 3 Aug 2016.